Regenerex Pharma (RGPX) Payables (2010 - 2025)
Regenerex Pharma (RGPX) reported Payables of $3.1 million for Q3 2025, up 1722.38% year-over-year from $168268.0 in Q3 2024, and up 1.73% on a QoQ basis from $3.0 million in Q2 2025.
Regenerex Pharma (RGPX) has 14 years of Payables data on file, last reported at $3.1 million in Q3 2025.
- Quarterly Payables rose 1722.38% year-over-year to $3.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.1 million (up 1722.38% YoY) and the FY2025 annual result came in at $3.0 million, up 1181.15% from the prior year.
- Payables grew to $3.1 million in Q3 2025 per RGPX's latest filing, from $3.0 million in the prior quarter.
- Across five years, Payables topped out at $3.1 million in Q3 2025 and bottomed at $162296.0 in Q2 2024.
- The 5-year median for Payables is $389849.0 (2023), against an average of $1.1 million.
- The widest annual swing landed in 2024, when Payables plunged 93.24%; it then soared 1757.35% in 2025.
- Tracing RGPX's Payables over 5 years: stood at $397567.0 in 2021, then gained by 1.49% to $403494.0 in 2022, then jumped by 514.37% to $2.5 million in 2023, then rose by 21.38% to $3.0 million in 2024, then rose by 1.91% to $3.1 million in 2025.
- Per Business Quant, the three latest RGPX Payables figures stand at $3.1 million (Q3 2025), $3.0 million (Q2 2025), and $3.0 million (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 3.02 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 168,268.00 |
| Jun 30, 2024 | 162,296.00 |
| Mar 31, 2024 | 235,874.00 |
| Dec 31, 2023 | 2.48 Mn |
| Sep 30, 2023 | 2.49 Mn |
| Jun 30, 2023 | 280,736.00 |
| Mar 31, 2023 | 389,849.00 |
| Dec 31, 2022 | 403,494.00 |
| Sep 30, 2022 | 321,855.00 |
| Jun 30, 2022 | 329,907.00 |
| Mar 31, 2022 | 403,513.00 |
| Dec 31, 2021 | 397,567.00 |
| Sep 30, 2021 | 222,038.00 |
| Jun 30, 2021 | 210,106.00 |
| Mar 21, 2021 | 272,215.00 |
| Dec 31, 2020 | 267,645.00 |
| Sep 30, 2020 | 227,637.00 |
| Jun 30, 2020 | 198,860.00 |
| Mar 31, 2020 | 272,821.00 |
| Dec 31, 2019 | 320,846.00 |
| Sep 30, 2019 | 304,830.00 |
| Jun 30, 2019 | 187,041.00 |
| Mar 31, 2019 | 108,348.00 |
| Dec 31, 2018 | 42,455.00 |
| Sep 30, 2018 | 53,454.00 |
| Jun 30, 2018 | 54,203.00 |
| Mar 31, 2018 | 37,870.00 |
| Dec 31, 2017 | 43,726.00 |
| Sep 30, 2017 | 42,230.00 |
| Jun 30, 2017 | 37,230.00 |
| Mar 31, 2017 | 37,230.00 |
| Nov 30, 2014 | 799,214.00 |
| Aug 31, 2014 | 757,599.00 |
| May 31, 2014 | 699,328.00 |
| Feb 28, 2014 | 1.91 Mn |
| Nov 30, 2013 | 1.75 Mn |
| Aug 31, 2013 | 1.42 Mn |
| May 31, 2013 | 465,000.00 |
| Feb 28, 2013 | 1.05 Mn |
| Nov 30, 2012 | 815,097.00 |
| Aug 31, 2012 | 334,308.00 |
| May 31, 2012 | 328,171.00 |
| Feb 29, 2012 | 329,100.00 |
| Nov 30, 2011 | 199,123.00 |
| Aug 31, 2011 | 38,046.00 |
| Nov 30, 2010 | 29,133.00 |